Type 3 Gaucher Disease
1 clinical trials · Condition
◉ Watch Type 3 Gaucher Disease
| Record | Firm | Date |
|---|---|---|
| Managed Access Program of Venglustat in Pediatric and Adult Patients With Type 3 Gaucher Disease (GD3). (NCT07675031) | Sanofi |
Track Type 3 Gaucher Disease automatically
Every clearance here is in the API, with alerts when new ones post.